Albumin Human Injection USP is a sterile intravenous plasma protein solution used in hospitals to restore and maintain blood volume in patients experiencing significant fluid loss or low serum albumin levels. It plays an important role in critical care, trauma management, burn treatment, liver disorders, and major surgeries. Human albumin solutions are typically available in concentrations such as 5%, 20%, and 25%, and are manufactured according to stringent pharmacopeial quality standards such as the United States Pharmacopeia (USP).
Medizalbu is a premium-quality Albumin Human Injection USP designed to meet the demanding requirements of healthcare professionals by delivering reliable plasma volume expansion and albumin replacement therapy.
Albumin Human Injection USP is prepared from carefully screened human plasma and is purified using validated manufacturing processes. Albumin is the most abundant protein in human plasma and is essential for maintaining oncotic pressure, transporting hormones, drugs, and fatty acids, and regulating fluid balance throughout the body. USP standards define the quality, purity, and labeling requirements for albumin products.
Product Name: Medizalbu
Medizalbu is developed to provide dependable plasma volume expansion and albumin replacement for hospitalized patients. Manufactured under strict quality control systems, it is intended for use by qualified healthcare professionals in hospitals and critical care settings.
Premium quality Albumin Human Injection USP
Sterile intravenous infusion
Manufactured under stringent quality standards
Reliable plasma volume replacement
Suitable for hospital and critical care use
Consistent product quality and safety
Healthcare professionals may prescribe Albumin Human Injection USP in appropriate clinical situations such as:
Hypoalbuminemia
Liver cirrhosis with albumin deficiency
Severe burns
Major surgery
Trauma and shock
Plasma volume expansion
Intensive care management
Therapeutic plasma exchange
Selected kidney disorders when clinically indicated
The specific indication, dose, and infusion rate should always be determined by the treating physician based on the patient's clinical condition.
Choosing Medizalbu offers several advantages:
Helps restore circulating blood volume
Supports maintenance of plasma oncotic pressure
Assists in correcting albumin deficiency
High-quality manufacturing standards
Reliable product for hospitals and healthcare institutions
Trusted solution for critical care management
Healthcare providers and pharmaceutical partners choose Medizalbu because of its commitment to quality and consistency.
High manufacturing standards
Consistent product quality
Professional technical support
Bulk supply availability
Third-party manufacturing opportunities
Distribution support across domestic and international markets
Albumin Human Injection USP should only be administered by trained healthcare professionals under medical supervision. Patients should be monitored during infusion for fluid status and potential infusion-related reactions. Product use should always follow the approved prescribing information and institutional protocols.
Medizalbu is available for:
Hospital procurement
Government tenders
Pharmaceutical distributors
Bulk supply
Third-party manufacturing
Contract manufacturing
Export partnerships
Private labeling opportunities
Albumin Human Injection USP remains an essential therapeutic option for managing plasma volume depletion and hypoalbuminemia in hospitalized patients. Medizalbu combines high manufacturing quality with dependable clinical performance, making it an excellent choice for hospitals, distributors, and pharmaceutical partners seeking a trusted human albumin solution.
For product information, bulk orders, third-party manufacturing, or distribution opportunities, contact Medizalbu today and discover reliable solutions for critical care medicine.